Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Ainhoa Escuela-EscobarInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0009-0002-8517-161X
Javier Perez-GarciaGenomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0000-0001-7813-4381
Elena Martín-GonzálezGenomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0000-0002-3522-3103
Cristina González MartínInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.
José M Hernández-PérezPulmonology Unit, Hospital Universitario N. S. de Candelaria (HUNSC), 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0002-2920-212X
Ruperto González PérezAllergy Department, Complejo Hospitalario Universitario de Canarias (HUC), 38320 San Cristóbal de La Laguna, Spain.ORCID 0000-0002-6664-0276
Inmaculada Sánchez MachínAllergy Department, Complejo Hospitalario Universitario de Canarias (HUC), 38320 San Cristóbal de La Laguna, Spain.ORCID 0000-0003-0109-8735
Paloma Poza GuedesAllergy Department, Complejo Hospitalario Universitario de Canarias (HUC), 38320 San Cristóbal de La Laguna, Spain.ORCID 0000-0001-8516-6648
Elena Mederos-LuisAllergy Department, Complejo Hospitalario Universitario de Canarias (HUC), 38320 San Cristóbal de La Laguna, Spain.ORCID 0000-0001-5298-6447
María Pino-YanesGenomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0000-0003-0332-437X
Fabian Lorenzo-DíazInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.
Mario A González CarracedoInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0000-0003-1386-0571
José A Pérez PérezInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.ORCID 0000-0003-0792-4647
Funding
co-financed by the Canarian Agency for Research, Innovation and the Information Society of the Counseling of Universities, Science and Innovation and Culture, and by the European Social Fund Plus (FSE+) Integrated Operational Program of the Canary Islands FPI2024010017co-financed by the Canarian Agency for Research, Innovation and the Information Society of the Counseling of Universities, Science and Innovation and Culture, and by the European Social Fund Plus (FSE+) Integrated Operational Program of the Canary Islands TESIS2022010045Fundación CajaCanarias and Fundación "la Caixa" 2022CLISA19MICIU/AEI/ 10.13039/501100011033 and by "ERDF A way of making Europe" SAF2017-83417R
6 · The paper itself
Abstract
The Canary Islands, a region with high asthma prevalence, are frequently exposed to Saharan Dust Intrusions (SDIs), as are a wide range of countries in Europe. Alpha-1 antitrypsin (
Indexed as
alpha 1-AntitrypsinAsthmaDustAdultAfrica, NorthernDNA, BacterialDNA, FungalFemaleHumansMaleMiddle AgedPolymorphism, Single NucleotideSalivaalpha 1-AntitrypsinDNA, BacterialDNA, FungalDustSERPINA1 protein, human16S rRNA18S rRNAasthmamicrobial DNA concentrationSaharan dust intrusionsSERPINA1SNV
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Impact of Saharan Dust and · full record | OpenQuestion